Ashburton Jersey Ltd maintained its stake in shares of CVS Health Corporation (NYSE:CVS) during the first quarter, Holdings Channel reports. The institutional investor owned 152,060 shares of the pharmacy operator’s stock at the end of the first quarter. CVS Health Corporation makes up 5.7% of Ashburton Jersey Ltd’s portfolio, making the stock its 10th largest position. Ashburton Jersey Ltd’s holdings in CVS Health Corporation were worth $11,937,000 as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Mercer Capital Advisers Inc. purchased a new stake in shares of CVS Health Corporation during the first quarter valued at approximately $118,000. Orrstown Financial Services Inc. increased its stake in shares of CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock valued at $165,000 after buying an additional 2,000 shares in the last quarter. SRS Capital Advisors Inc. increased its stake in shares of CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares in the last quarter. Edmp Inc. purchased a new stake in shares of CVS Health Corporation during the first quarter valued at approximately $202,000. Finally, Pinnacle Bank purchased a new stake in shares of CVS Health Corporation during the first quarter valued at approximately $203,000. Institutional investors own 82.31% of the company’s stock.

Shares of CVS Health Corporation (CVS) traded down 0.05% during mid-day trading on Tuesday, reaching $79.26. The company’s stock had a trading volume of 394,082 shares. The firm has a market cap of $80.57 billion, a PE ratio of 15.79 and a beta of 0.91. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44. The company has a 50-day moving average of $78.89 and a 200-day moving average of $78.94.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analyst estimates of $45.36 billion. During the same period last year, the firm posted $1.32 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date was Thursday, July 20th. CVS Health Corporation’s payout ratio is 39.92%.

COPYRIGHT VIOLATION NOTICE: “Ashburton Jersey Ltd Maintains Position in CVS Health Corporation (CVS)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/15/ashburton-jersey-ltd-maintains-position-in-cvs-health-corporation-cvs.html.

CVS has been the topic of several recent analyst reports. Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the company a “buy” rating in a research note on Tuesday, June 27th. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 target price on the stock. in a research note on Monday, June 12th. Tigress Financial initiated coverage on shares of CVS Health Corporation in a research note on Thursday, April 27th. They issued a “buy” rating on the stock. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Finally, ValuEngine downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $92.04.

In other news, CFO David M. Denton sold 230,510 shares of CVS Health Corporation stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the sale, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at $14,158,640. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Helena Foulkes sold 20,333 shares of CVS Health Corporation stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $80.00, for a total value of $1,626,640.00. Following the sale, the executive vice president now directly owns 59,301 shares in the company, valued at $4,744,080. The disclosure for this sale can be found here. Insiders have sold 271,175 shares of company stock worth $21,632,597 over the last three months. Insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.